Prognostic and predictive factors: treatment of lung cancer

E-poster session
Chairs: J. Domagala-Kulawik (Warszawa, Poland), D. Jovanovic (Beograd, Republic of Serbia)

The importance of Ki-67 proliferation index in small cell lung cancer S. Beyhan Sagmen (Istanbul, Turkey), C. Dogan (Istanbul, Turkey), S. Comert (Istanbul, Turkey), N. Kiral (Istanbul, Turkey), E. Torun Parmaksiz (Istanbul, Turkey), A. Fidan (Istanbul, Turkey), N. Ozdemir Barisik (Istanbul, Turkey), S. Karabulut Gul (Istanbul, Turkey)
Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC N. K.Dezfuli (Tehran, Islamic Republic of Iran), S. D.Alipour (Tehran, Islamic Republic of Iran), N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), A. Khosravi (Tehran, Islamic Republic of Iran), B. Salimi (Tehran, Islamic Republic of Iran), I. Adcock (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran)
A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD A. Hummersgaard Hansen (Herlev, Denmark), J. Marie Bülow Sand (Herlev, Denmark), D. Julie Leeming (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), S. Sun (Herlev, Denmark), M. Karsdal (Herlev, Denmark), A. Lynge Reese-Petersen (Herlev, Denmark), F. Genovese (Herlev, Denmark)
Evaluation of serum levels of Sirtuin-1 in lung cancer patients H. Ghobadi-Marallu (Ardabil, Islamic Republic of Iran), S. Hosseininia (Ardabil, Islamic Republic of Iran), A. Ameli (Ardabil, Islamic Republic of Iran), F. Pourfarzi (Ardabil, Islamic Republic of Iran), M. Aslani (Ardabil, Islamic Republic of Iran)
Type XIX collagen quantified in serum targeting the anti-tumorigenic NC1 domain is elevated in early and late stage lung carcinoma patients and COPD D. Leeming (Herlev, Denmark), J. Thorlacius-Usssing (Herlev, Denmark), J. Sand (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), S. Sun (Herlev, Denmark), M. Karsdal (Herlev, Denmark), N. Villumsen (Herlev, Denmark)
Role of complement activation product C4d as apredictor biomarker in lung cancer diagnosis : case control study L. Suliman (Mansoura, Egypt), D. Abo Elkhair (Mansoura, Egypt), A. Moawad (Mansoura, Egypt), H. Shehawy (Mansoura, Egypt)
Response to Immunotherapy in non-small cell lung cancer: the effect of weight A. Fernandes (Matosinhos, Portugal), M. Dias (Vila Nova de Gaia, Portugal), A. Alves (Vila Nova de Gaia, Portugal), D. Coutinho (Vila Nova de Gaia, Portugal), E. Silva (Vila Nova de Gaia, Portugal), T. Costa (Vila Nova de Gaia, Portugal), S. Campainha (Vila Nova de Gaia, Portugal), S. Conde (Vila Nova de Gaia, Portugal), A. Barroso (Vila Nova de Gaia, Portugal)
Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer. M. Aparicio Vicente (Murcia, Spain), E. García Pachón (Elche, Spain), S. Ruiz Martínez (Murcia, Spain), L. Fernández Mula (Murcia, Spain)
Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer H. Racil (Ariana, Tunisia), H. Kchouk (Ariana, Tunisia), A. Ezzaouia (Ariana, Tunisia), S. Maazaoui (Ariana, Tunisia), S. Habibech (Ariana, Tunisia), A. Ayadi (Ariana, Tunisia), N. Chaouch (Ariana, Tunisia)
Short-term efficacy of advanced NSCLC patients receiving anlotinib hydrochloride as the first and second-line treatment C. Changning (Xi’an, China), Y. Zhang (Xi’an, China), J. Zhang (Xi’an, China)
Our experience with crizotinib in the treatment of non-small cell lung cancer N. Aksel (Izmir, Turkey), M. Gayaf (Izmir, Turkey), G. Ari (Izmir, Turkey), M. Akyol (Izmir, Turkey)
Clinical efficacy of 1st line EGFR-TKIs for NSCLC habouring EGFR mutation with high PD-L1 expression; A single-centered retrospective study Y. Nakamura (Matsusaka City, Mie Prefecture, Japan), O. Hataji (Matsusaka City, Mie Prefecture, Japan), K. Furuhashi (Matsusaka City, Mie Prefecture, Japan), Y. Suzuki (Matsusaka City, Mie Prefecture, Japan), T. Sakaguchi (Matsusaka City, Mie Prefecture, Japan), K. Ito (Matsusaka City, Mie Prefecture, Japan), K. Fujiwara (Matsusaka City, Mie Prefecture, Japan), Y. Nishii (Matsusaka City, Mie Prefecture, Japan), O. Taguchi (Matsusaka City, Mie Prefecture, Japan), E. Gabazza (Tsu, Japan)
Neurological abnormalities and syphilitic serologic variation with nivolumab : a case of neurosyphilis? M. FERREIRA (TOURS, France), F. Bastides (TOURS, France), E. Pichon (TOURS, France), F. Lisée (TOURS, France), S. Marchand-Adam (TOURS, France), T. Flament (TOURS, France)
Compression therapy using surgical gloves and elastic stockings to prevent chemotherapy induced peripheral neuropathy (CIPN) in advanced non-small cell lung cancer. Y. Kida (Kobe, Japan), R. Kouketsu (Kobe, Japan), T. Sakurai (Kobe, Japan), Y. Inui (Kobe, Japan), T. Matsuoka (Kobe, Japan), K. Tada (Kobe, Japan)
Synchronous multiple primary lung cancers manifesting as multiple ground-glass nodules define a special clinical subtype W. Luo (Chengdu, China), W. Li (Chengdu, China)
Association between young age and genomic alterations in never-smoker patients with non–small cell lung cancer W. Luo (Chengdu, China), W. Li (Chengdu, China)
Unique clinicopathological characteristics and favorable prognosis of young patients with non-small cell lung cancer W. Luo (Chengdu, China), W. Li (Chengdu, China)
Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital. M. Shuvo (Colchester (Essex), United Kingdom), F. Jarvis (Colchester (Essex), United Kingdom), R. Lee (Colchester (Essex), United Kingdom), L. Wright (Colchester (Essex), United Kingdom), R. Badiger (Colchester (Essex), United Kingdom), P. Hawkins (Colchester (Essex), United Kingdom)
Tunnelled indwelling pleural catheters inserted post thoracoscopy E. Shiels (Newport, United Kingdom), P. Evans (Newport, United Kingdom), A. Ionescu (Newport, United Kingdom)